TSBX Turnstone Biologics
- 2.610
- -0.020-0.76%
- 2.680
- +0.070+2.68%
Turnstone Biologics News
Turnstone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy J. Langer(4.3%)
Turnstone Biologics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Turnstone Biologics | 10-Q: Quarterly report
Turnstone Biologics | 8-K: Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(5.994%),Abigail P. Johnson(5.994%)
Turnstone Biologics | ARS: Annual Report to Security Holders
Turnstone Biologics | DEFA14A: Others
Turnstone Biologics | DEF 14A: Definitive information statements
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Turnstone Biologics | 3: Initial statement of beneficial ownership of securities-Director Waddill William D.
Turnstone Biologics | 8-K: Current report
Turnstone Biologics | 10-K: Annual report
Turnstone Biologics | 8-K: Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Turnstone Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Timothy J. Langer(5.6%)
Turnstone Biologics | 8-K: Current report
Turnstone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(11.027%),Abigail P. Johnson(11.027%)
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities- FMR LLC
Turnstone Biologics | 10-Q: Quarterly report
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Ramanan Venkat
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Rajangam Kanya
Analysis
Price Target
No Data
